As of Sep 30
| +0.08 / +2.84%|
The 1 analysts offering 12-month price forecasts for PharmAthene Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +106.90% increase from the last price of 2.90.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.